Company Profile
Envita Interventional Radiology
Company Overview
Envita Interventional Radiology has over 20 years of experience treating difficult and complex late-stage cancer diagnoses, Envita Medical Centers realized the untapped potential of non-invasive interventional surgical procedures early-on and has worked tirelessly to advance the art, science, technology, and precision of these procedures to the benefit of our patients.
Next-level genetic testing has always been at the core of Envita Medical Centers’ treatment planning for late-stage and complex cancers and that level of detailed diagnostics has been integral in EnvitaIR’s™ success.
This is a very exciting time for interventional radiology oncology at EnvitaIR™. What we have discovered in our two decades of cancer treatment development at Envita Medical Centers is that precision targeting and personalized treatment selection makes all the difference for our patients, especially those who have failed treatment elsewhere.
EnvitaIR™ has developed advanced interventional oncology solutions using the latest in chemotherapy, radiation, and ablation therapy to shrink or destroy tumors. By working with Envita Medical Centers’ molecular tumor board and advanced immunotherapy targeting, EnvitaIR™ determines the treatment options the patient has the best chance to respond to, providing next-level precision care in oncology.
In our clinical opinion, the effectiveness of EnvitaIR™ comes from the ability to provide targeted late-stage cancer treatment options far beyond what is available from traditional interventional radiology and surgical means. These minimally invasive alternatives to standard surgery have the advantage of delivering custom drug algorithms, even when traditional surgery is not a viable option, which can make all the difference for complex cancer diagnoses.
Utilizing Envita Medical Center's 20 years of experience in advanced targeting, immunotherapy, epigenetics, and genomics, EnvitaIR™ is set to revolutionize the field on interventional radiology with patient tailored options designed to deliver the best health outcomes possible.
Company History
Envita Interventional Radiology (EnvitaIR™) was launched as a specialized extension of Envita Medical Centers focused on image-guided minimally invasive oncology procedures and precision tumor targeting. EnvitaIR was formally founded in 2021.
Why EnvitaIR Was Created
Envita Medical Centers had already spent years building:
- genomic precision targeting
- customized oncology therapies
- immune-based treatments
- personalized infusion medicine
The next strategic evolution was improving how therapies were physically delivered into tumors.
EnvitaIR was created to:
- deliver therapies directly into tumors
- reduce systemic toxicity
- improve concentration of medications at tumor sites
- combine imaging technology with precision medicine
- create minimally invasive alternatives to traditional surgical oncology approaches
This aligned closely with broader industry trends in:
- interventional oncology
- catheter-based cancer treatment
- localized immunotherapy delivery
- tumor embolization
- image-guided ablation
- minimally invasive procedures
Core Technologies and Procedures
The flagship technology heavily associated with EnvitaIR is:
CIPI™
(Chemo Immuno Precision Injection)
This proprietary procedure combines:
- interventional radiology
- catheter-guided delivery
- customized chemotherapy
- customized immunotherapy
- genomic targeting
- tumor-specific medication deployment
The concept is to:
Analyze the patient’s tumor genomics
Customize a targeted therapeutic combination
Deliver that combination directly into the tumor through catheter-based procedures
Envita claims this allows:
- higher local drug concentration
- reduced systemic side effects
- more targeted tumor destruction
- faster recovery
- improved precision delivery
Interventional Radiology Focus Areas
EnvitaIR focuses on:
- minimally invasive image-guided procedures
- targeted cancer injections
- localized immunotherapy delivery
- catheter-based oncology procedures
- precision tumor targeting
- advanced imaging-guided interventions
Their positioning attempts to blend:
- traditional interventional radiology
- precision oncology
- immunotherapy
- integrative oncology principles
This makes EnvitaIR somewhat unique in branding because it sits between:
- a traditional IR practice
- an oncology center
- a precision medicine program
- a proprietary treatment platform
Leadership and Medical Expertise
One of the key physicians associated with EnvitaIR is Dr. David M. Medina, an experienced interventional radiologist with more than 25 years of IR and oncology experience. Prior to joining EnvitaIR, he served as Director of Interventional Radiology at Chandler Radiology Associates from 1999 to 2021.
The organization also leverages specialists in:
- oncology
- genomics
- immunology
- infusion medicine
- radiology
- integrative medicine
Notable Accomplishments / Recognition
Notable Accomplishments of Envita Interventional Radiology (EnvitaIR™)
- Developed the proprietary CIPI™ (Chemo Immuno Precision Injection) platform, an advanced precision oncology procedure that combines Interventional Radiology, genomics, immunotherapy, and direct-to-tumor targeted therapy delivery.
- Built one of the few Interventional Radiology programs in the country fully integrated with molecular tumor profiling, genomic targeting, and personalized precision oncology treatment design.
- Advanced minimally invasive, image-guided oncology procedures designed to deliver personalized therapies directly into tumors while reducing systemic toxicity and recovery times compared to traditional surgery and standard chemotherapy delivery methods.
- Created proprietary Tumor Specific Precision Injection (TSPI™) methodologies utilizing individualized genomic, immunologic, and transcriptional profiling to customize treatment deployment for each patient.
Successfully integrated Interventional Radiology into Envita’s broader precision oncology ecosystem, combining:
- Genomics
- Immunotherapy
- Molecular diagnostics
- Customized oncology drug algorithms
- Integrative oncology care
- Advanced catheter-based tumor targeting technologies.
- Helped position Envita as an innovation-focused precision oncology organization attracting complex, advanced-stage, and international cancer patients seeking alternatives beyond conventional treatment models.
- Published clinical outcome and precision oncology research related to direct-to-tumor interventional oncology methodologies and personalized cancer treatment approaches.
- Developed outpatient minimally invasive oncology procedures that often avoid:
- major surgery
- large incisions
- extended hospital stays
- general anesthesia
- while supporting faster recovery and precision-targeted care.
- Established a multidisciplinary precision oncology team including:
- Interventional Radiologists
- Oncology specialists
- Genomics experts
- Immunotherapy specialists
- Pharmacists
- Molecular tumor board collaboration.
- Expanded Envita Medical Centers beyond traditional integrative oncology into advanced precision Interventional Oncology and image-guided tumor
Positions Available
- Viewing 1 - 1 of 1 Jobs